Companies ›Real Estate ›REG.AX

REG.AX — ASX Commercial REITs

Regis Healthcare Ltd

A$6,14

Open in Charts → Attach watcher ⌖

— —

AUD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

3,50 %

Op margin

5,2 %

ROE

-292,7 %

Net margin

4,2 %

Debt / equity

-0,31

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

2026-10-28

Ex-dividend

—

TR 1Y

—

About

Regis Healthcare Ltd operates in the healthcare facilities and services industry, providing pharmaceutical and healthcare services to patients and healthcare providers.

Business. Regis Healthcare Ltd (REG.AX) is a healthcare services and equipment company primarily engaged in pharmaceuticals and healthcare facilities and services. The firm operates within the Healthcare sector, generating revenue through service-based models typical of the industry. Regis Healthcare is headquartered in Australia and is listed on the Australian Securities Exchange (ASX). Specific details regarding operating segments and geographic breakdowns are not available.

Classification99 %

SectorReal Estate

Industry groupCommercial REITs

Generated · model-assisted

Sell-side consensus

BUY5 analysts

4 buy1 hold0 sell

Avg 12m price target8,46

Analyst recommendations

5 analysts · consensus Buy

Buy4

Hold1

Sell0

12-month price target

8,46

Consensus of sell-side coverage.

Upcoming events

EarningsQ3 2026 earnings (expected)2026-10-28 · estimated

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Buy

5 analysts · indicative

Ownership

—

not yet wired

Profitability→

-292,7 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning REG.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate · THIS SECTOR−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to REG.AX. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Company
EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR
Congressional trades
CongressKathy Manning — Regency Centers Corporation2022-08-03 · NC · Sale · $1,001 - $15,000

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Regis Healthcare Ltd (REG.AX) is a healthcare services and equipment company primarily engaged in pharmaceuticals and healthcare facilities and services. The firm operates within the Healthcare sector, generating revenue through service-based models typical of the industry. Regis Healthcare is headquartered in Australia and is listed on the Australian Securities Exchange (ASX). Specific details regarding operating segments and geographic breakdowns are not available.

Classification99 %

SectorReal Estate

Industry groupCommercial REITs

AI synthesis

GENERATED

Regis Healthcare Ltd has a negative equity position of -16.72 million AUD, indicating a significant financial challenge in its capital structure. The company's liquidity is further constrained by a current ratio of 0.11, suggesting that it may struggle to meet short-term obligations with its current assets. Despite this, the company reported an operating cash flow of 306.11 million AUD, which is a positive sign of operational efficiency. However, the free cash flow is negative at -32.07 million AUD, indicating that the company is spending more on capital expenditures than it is generating in cash.

In terms of profitability, the company's return on assets is 2.33%, which is relatively low and suggests that the company is not effectively utilizing its assets to generate profit. The return on equity is negative at -292.7%, indicating that the company is not generating returns for its shareholders and is, in fact, losing value. These metrics are below the industry median for healthcare facilities and services, highlighting a need for operational improvements.

The company's revenue is primarily concentrated in its core healthcare services, with no significant diversification across segments or geographic regions disclosed in the available data. This lack of diversification could pose a risk if the company's primary market experiences a downturn. The company's growth trajectory is also uncertain, as there are no specific numeric deltas provided for the current or next fiscal year.

The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key flag, suggesting potential liquidity constraints. The dilution risk is low, which is a positive aspect for shareholders, as it indicates that the company is not likely to issue additional shares that could dilute existing ownership.

Recent events and filings have not been disclosed in the available data, so there is no information on specific recent developments that could impact the company's operations or financial position. The company's financial health and strategic direction will need to be closely monitored to assess its ability to navigate potential challenges and capitalize on opportunities in the healthcare sector.

Key takeaways

Regis Healthcare Ltd has a negative equity position, indicating a significant financial challenge.
The company's liquidity is constrained, with a current ratio of 0.11 and a negative free cash flow.
The company's return on equity is negative, suggesting that it is not generating returns for its shareholders.
The company's revenue is primarily concentrated in its core healthcare services, with no significant diversification.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year.

Bull / Bear case

Generated · model-assisted

— missing data

In focus — financials by report

Valuation

Market price

A$6,14

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

-A$16.7M

Net cashⓘ

-A$5.1M

Current ratioⓘ

0.1

Debt / equityⓘ

-0.3

ROAⓘ

2.3%

ROEⓘ

-2.9%

Cash conversionⓘ

625.0%

CapEx / revenueⓘ

-7.4%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Retail / Shopping Centres—

low · llm_fanout_v2

Retail Properties—

low · llm_fanout_v2

Business relationships

Business relationships473 disclosed relationships · 1 type · extracted from filings & disclosures

Subsidiaries473

EX21:0058dad699c4EX21:0058dad699c4Subsidiarie97%

EX21:0084778b6023EX21:0084778b6023Subsidiarie97%

EX21:009218775986EX21:009218775986Subsidiarie97%

EX21:0111ffc93e51EX21:0111ffc93e51Subsidiarie97%

EX21:0178b5378715EX21:0178b5378715Subsidiarie97%

EX21:0192e25dfbbeEX21:0192e25dfbbeSubsidiarie97%

EX21:01cf3536c311EX21:01cf3536c311Subsidiarie97%

EX21:01e7bbea6313EX21:01e7bbea6313Subsidiarie97%

EX21:020a1ebe5b71EX21:020a1ebe5b71Subsidiarie97%

EX21:020edf7bf3adEX21:020edf7bf3adSubsidiarie97%

EX21:024779850b6fEX21:024779850b6fSubsidiarie97%

EX21:02cad6ccbc25EX21:02cad6ccbc25Subsidiarie97%

EX21:036363e2b169EX21:036363e2b169Subsidiarie97%

EX21:03dfd538868aEX21:03dfd538868aSubsidiarie97%

EX21:042d67aa8cdeEX21:042d67aa8cdeSubsidiarie97%

EX21:04ced782e5afEX21:04ced782e5afSubsidiarie97%

EX21:053156c6c153EX21:053156c6c153Subsidiarie97%

EX21:0650b60e73cbEX21:0650b60e73cbSubsidiarie97%

EX21:075b9ba42d5fEX21:075b9ba42d5fSubsidiarie97%

EX21:07715984b3ceEX21:07715984b3ceSubsidiarie97%

EX21:0874b9caf732EX21:0874b9caf732Subsidiarie97%

EX21:08d4f41e69feEX21:08d4f41e69feSubsidiarie97%

EX21:09227c730f25EX21:09227c730f25Subsidiarie97%

EX21:0a5369c0579bEX21:0a5369c0579bSubsidiarie97%

EX21:0a75b01de90cEX21:0a75b01de90cSubsidiarie97%

EX21:0b0bf9c3b84bEX21:0b0bf9c3b84bSubsidiarie97%

EX21:0bf8246e80c9EX21:0bf8246e80c9Subsidiarie97%

EX21:0c2b569e1011EX21:0c2b569e1011Subsidiarie97%

EX21:0d17008a9f5bEX21:0d17008a9f5bSubsidiarie97%

EX21:0d1f39a5b596EX21:0d1f39a5b596Subsidiarie97%

EX21:0d51bf2d7dfaEX21:0d51bf2d7dfaSubsidiarie97%

EX21:0d8a06378c66EX21:0d8a06378c66Subsidiarie97%

EX21:0df4f282097bEX21:0df4f282097bSubsidiarie97%

EX21:0e0598493304EX21:0e0598493304Subsidiarie97%

EX21:0e27fb8193a4EX21:0e27fb8193a4Subsidiarie97%

EX21:0e3639cb8f4cEX21:0e3639cb8f4cSubsidiarie97%

EX21:0eaeca289bf8EX21:0eaeca289bf8Subsidiarie97%

EX21:0eda6f2d18acEX21:0eda6f2d18acSubsidiarie97%

EX21:1044dd5ba93cEX21:1044dd5ba93cSubsidiarie97%

EX21:10575732aa2fEX21:10575732aa2fSubsidiarie97%

EX21:10b07357dbceEX21:10b07357dbceSubsidiarie97%

EX21:1159e95f0d79EX21:1159e95f0d79Subsidiarie97%

EX21:13711dccd1eeEX21:13711dccd1eeSubsidiarie97%

EX21:137b7599e281EX21:137b7599e281Subsidiarie97%

EX21:14bd208c3e41EX21:14bd208c3e41Subsidiarie97%

EX21:159de23d2155EX21:159de23d2155Subsidiarie97%

EX21:15b5142c29ebEX21:15b5142c29ebSubsidiarie97%

EX21:15cac7f3de3dEX21:15cac7f3de3dSubsidiarie97%

EX21:16437ae5784cEX21:16437ae5784cSubsidiarie97%

EX21:168fa1bcb41bEX21:168fa1bcb41bSubsidiarie97%

EX21:1802a3b56caeEX21:1802a3b56caeSubsidiarie97%

EX21:188c06ab7ad5EX21:188c06ab7ad5Subsidiarie97%

EX21:18e9c78272dfEX21:18e9c78272dfSubsidiarie97%

EX21:1b2f039d30b8EX21:1b2f039d30b8Subsidiarie97%

EX21:1c6d163b3060EX21:1c6d163b3060Subsidiarie97%

EX21:1cc8e284c5d8EX21:1cc8e284c5d8Subsidiarie97%

EX21:1d2218efce69EX21:1d2218efce69Subsidiarie97%

EX21:1d432ff45ac2EX21:1d432ff45ac2Subsidiarie97%

EX21:1e2cb398efa7EX21:1e2cb398efa7Subsidiarie97%

EX21:1e30138f155aEX21:1e30138f155aSubsidiarie97%

EX21:1e9b7cbe17dfEX21:1e9b7cbe17dfSubsidiarie97%

EX21:1eda7d8e26c8EX21:1eda7d8e26c8Subsidiarie97%

EX21:1eeed1fa4d33EX21:1eeed1fa4d33Subsidiarie97%

EX21:1f014d774717EX21:1f014d774717Subsidiarie97%

EX21:1f1ff72a8a78EX21:1f1ff72a8a78Subsidiarie97%

EX21:1f41fc548164EX21:1f41fc548164Subsidiarie97%

EX21:1fd6d76c6e80EX21:1fd6d76c6e80Subsidiarie97%

EX21:203c8d0a37b5EX21:203c8d0a37b5Subsidiarie97%

EX21:208ddf691e85EX21:208ddf691e85Subsidiarie97%

EX21:22d2dc0fd059EX21:22d2dc0fd059Subsidiarie97%

EX21:22d79edf66a0EX21:22d79edf66a0Subsidiarie97%

EX21:237d8fd5bec3EX21:237d8fd5bec3Subsidiarie97%

EX21:23a3c66e52d7EX21:23a3c66e52d7Subsidiarie97%

EX21:23d5c40dedd5EX21:23d5c40dedd5Subsidiarie97%

EX21:24ae4a24a796EX21:24ae4a24a796Subsidiarie97%

EX21:24bd47882b8bEX21:24bd47882b8bSubsidiarie97%

EX21:25c60f8f21ccEX21:25c60f8f21ccSubsidiarie97%

EX21:25fea067765aEX21:25fea067765aSubsidiarie97%

EX21:2655b66984eaEX21:2655b66984eaSubsidiarie97%

EX21:26ea310ef9c7EX21:26ea310ef9c7Subsidiarie97%

EX21:27054262d612EX21:27054262d612Subsidiarie97%

EX21:273eb53f4f29EX21:273eb53f4f29Subsidiarie97%

EX21:279289b0d026EX21:279289b0d026Subsidiarie97%

EX21:27e5f30bb788EX21:27e5f30bb788Subsidiarie97%

EX21:27ee6859dd11EX21:27ee6859dd11Subsidiarie97%

EX21:281581b84cf8EX21:281581b84cf8Subsidiarie97%

EX21:281bfa76d19eEX21:281bfa76d19eSubsidiarie97%

EX21:2834d8cb0984EX21:2834d8cb0984Subsidiarie97%

EX21:28c2d377f4f8EX21:28c2d377f4f8Subsidiarie97%

EX21:2a433bf7b658EX21:2a433bf7b658Subsidiarie97%

EX21:2ab5c6f2f445EX21:2ab5c6f2f445Subsidiarie97%

EX21:2ae16d894d79EX21:2ae16d894d79Subsidiarie97%

EX21:2b1390a86ff6EX21:2b1390a86ff6Subsidiarie97%

EX21:2e749fa93f12EX21:2e749fa93f12Subsidiarie97%

EX21:2eaffeb7218dEX21:2eaffeb7218dSubsidiarie97%

EX21:2f1d4da233f3EX21:2f1d4da233f3Subsidiarie97%

EX21:2f2e5da21b3cEX21:2f2e5da21b3cSubsidiarie97%

EX21:2f53ef15f9eeEX21:2f53ef15f9eeSubsidiarie97%

EX21:2f8fd7e7a162EX21:2f8fd7e7a162Subsidiarie97%

EX21:2f9252536ba0EX21:2f9252536ba0Subsidiarie97%

EX21:2ff095ae289eEX21:2ff095ae289eSubsidiarie97%

EX21:304da5837ac3EX21:304da5837ac3Subsidiarie97%

EX21:31b02ed5e690EX21:31b02ed5e690Subsidiarie97%

EX21:321b251a5d4eEX21:321b251a5d4eSubsidiarie97%

EX21:32761dd54a89EX21:32761dd54a89Subsidiarie97%

EX21:32f1f2eb54cfEX21:32f1f2eb54cfSubsidiarie97%

EX21:333390270f95EX21:333390270f95Subsidiarie97%

EX21:3358b12ac6e0EX21:3358b12ac6e0Subsidiarie97%

EX21:345883ea538cEX21:345883ea538cSubsidiarie97%

EX21:357c2628f6a7EX21:357c2628f6a7Subsidiarie97%

EX21:372e88a0d484EX21:372e88a0d484Subsidiarie97%

EX21:396c98a47311EX21:396c98a47311Subsidiarie97%

EX21:3a23afc04245EX21:3a23afc04245Subsidiarie97%

EX21:3a4c534aecc9EX21:3a4c534aecc9Subsidiarie97%

EX21:3a9a48d663adEX21:3a9a48d663adSubsidiarie97%

EX21:3b441717bf45EX21:3b441717bf45Subsidiarie97%

EX21:3b6f654ca343EX21:3b6f654ca343Subsidiarie97%

EX21:3bb75a450056EX21:3bb75a450056Subsidiarie97%

EX21:3bf22aa0a784EX21:3bf22aa0a784Subsidiarie97%

EX21:3dbca4c50675EX21:3dbca4c50675Subsidiarie97%

EX21:3e6426e3ea76EX21:3e6426e3ea76Subsidiarie97%

EX21:3e959b6dbe18EX21:3e959b6dbe18Subsidiarie97%

EX21:3ebb637a6889EX21:3ebb637a6889Subsidiarie97%

EX21:3f890939ce25EX21:3f890939ce25Subsidiarie97%

EX21:4054e0a9f4e9EX21:4054e0a9f4e9Subsidiarie97%

EX21:406ffa602e52EX21:406ffa602e52Subsidiarie97%

EX21:407b7611feb5EX21:407b7611feb5Subsidiarie97%

EX21:4133ff5bd790EX21:4133ff5bd790Subsidiarie97%

EX21:4192ff315e3bEX21:4192ff315e3bSubsidiarie97%

EX21:41ac45ec1b36EX21:41ac45ec1b36Subsidiarie97%

EX21:41c72293768eEX21:41c72293768eSubsidiarie97%

EX21:42e147df86fbEX21:42e147df86fbSubsidiarie97%

EX21:42ff52afb5ccEX21:42ff52afb5ccSubsidiarie97%

EX21:431c437ce32eEX21:431c437ce32eSubsidiarie97%

EX21:43657895324cEX21:43657895324cSubsidiarie97%

EX21:43b697720a56EX21:43b697720a56Subsidiarie97%

EX21:4413579eff51EX21:4413579eff51Subsidiarie97%

EX21:4435dca7b07aEX21:4435dca7b07aSubsidiarie97%

EX21:44f430526353EX21:44f430526353Subsidiarie97%

EX21:45edb9c42f5eEX21:45edb9c42f5eSubsidiarie97%

EX21:462cbff5fd8fEX21:462cbff5fd8fSubsidiarie97%

EX21:46d76be099dcEX21:46d76be099dcSubsidiarie97%

EX21:46dc80907aa0EX21:46dc80907aa0Subsidiarie97%

EX21:46ea017978bfEX21:46ea017978bfSubsidiarie97%

EX21:470a459e2308EX21:470a459e2308Subsidiarie97%

EX21:48dceb953b34EX21:48dceb953b34Subsidiarie97%

EX21:496d398499b1EX21:496d398499b1Subsidiarie97%

EX21:4a0bec9acb20EX21:4a0bec9acb20Subsidiarie97%

EX21:4b7ec0025cfaEX21:4b7ec0025cfaSubsidiarie97%

EX21:4c4d876c6830EX21:4c4d876c6830Subsidiarie97%

EX21:4c9ff71d2dc1EX21:4c9ff71d2dc1Subsidiarie97%

EX21:4cd6574ac27bEX21:4cd6574ac27bSubsidiarie97%

EX21:4d39a2c9c742EX21:4d39a2c9c742Subsidiarie97%

EX21:4d41f69a1129EX21:4d41f69a1129Subsidiarie97%

EX21:4d4b77afa12cEX21:4d4b77afa12cSubsidiarie97%

EX21:4de1d714240cEX21:4de1d714240cSubsidiarie97%

EX21:4dfcdbb68ae9EX21:4dfcdbb68ae9Subsidiarie97%

EX21:4e4c1b0fe6e2EX21:4e4c1b0fe6e2Subsidiarie97%

EX21:4e70ed07bacaEX21:4e70ed07bacaSubsidiarie97%

EX21:4f2de2306aa5EX21:4f2de2306aa5Subsidiarie97%

EX21:4f32d7fcd336EX21:4f32d7fcd336Subsidiarie97%

EX21:4f44befe7707EX21:4f44befe7707Subsidiarie97%

EX21:4fbee12f641aEX21:4fbee12f641aSubsidiarie97%

EX21:4feed265d17dEX21:4feed265d17dSubsidiarie97%

EX21:50f258b80222EX21:50f258b80222Subsidiarie97%

EX21:50fbadf134bcEX21:50fbadf134bcSubsidiarie97%

EX21:513ce872a518EX21:513ce872a518Subsidiarie97%

EX21:51e427147322EX21:51e427147322Subsidiarie97%

EX21:521df115a3d1EX21:521df115a3d1Subsidiarie97%

EX21:523ab0aefadcEX21:523ab0aefadcSubsidiarie97%

EX21:528d1320d62dEX21:528d1320d62dSubsidiarie97%

EX21:5290c40dac7eEX21:5290c40dac7eSubsidiarie97%

EX21:533b333ebc15EX21:533b333ebc15Subsidiarie97%

EX21:539dafed83faEX21:539dafed83faSubsidiarie97%

EX21:547b206322b5EX21:547b206322b5Subsidiarie97%

EX21:549336221cf9EX21:549336221cf9Subsidiarie97%

EX21:54dc26be8c0bEX21:54dc26be8c0bSubsidiarie97%

EX21:54ed57791436EX21:54ed57791436Subsidiarie97%

EX21:54ee3c118f23EX21:54ee3c118f23Subsidiarie97%

EX21:55224aeaffaaEX21:55224aeaffaaSubsidiarie97%

EX21:552a49903a9aEX21:552a49903a9aSubsidiarie97%

EX21:552cc4acf571EX21:552cc4acf571Subsidiarie97%

EX21:55acaab7d7a4EX21:55acaab7d7a4Subsidiarie97%

EX21:5753d6497f86EX21:5753d6497f86Subsidiarie97%

EX21:5788f5160a91EX21:5788f5160a91Subsidiarie97%

EX21:57e58c2b4277EX21:57e58c2b4277Subsidiarie97%

EX21:58186b6b85bdEX21:58186b6b85bdSubsidiarie97%

EX21:58fe001c1d19EX21:58fe001c1d19Subsidiarie97%

EX21:59a0659d146dEX21:59a0659d146dSubsidiarie97%

EX21:5a573714c7c9EX21:5a573714c7c9Subsidiarie97%

EX21:5a686049a7a3EX21:5a686049a7a3Subsidiarie97%

EX21:5ba5381dc3ddEX21:5ba5381dc3ddSubsidiarie97%

EX21:5c16ac4330f6EX21:5c16ac4330f6Subsidiarie97%

EX21:5ce39bb16574EX21:5ce39bb16574Subsidiarie97%

EX21:5cef3b9eb131EX21:5cef3b9eb131Subsidiarie97%

EX21:5da4b69db2b3EX21:5da4b69db2b3Subsidiarie97%

EX21:5dfa9ac12480EX21:5dfa9ac12480Subsidiarie97%

EX21:5e292ca94582EX21:5e292ca94582Subsidiarie97%

EX21:5e327647a869EX21:5e327647a869Subsidiarie97%

EX21:5e537a092311EX21:5e537a092311Subsidiarie97%

EX21:5f5906c568f1EX21:5f5906c568f1Subsidiarie97%

EX21:5fe8fe1e2f47EX21:5fe8fe1e2f47Subsidiarie97%

EX21:5ff0c6966876EX21:5ff0c6966876Subsidiarie97%

EX21:6068cc068110EX21:6068cc068110Subsidiarie97%

EX21:60f90d1f8404EX21:60f90d1f8404Subsidiarie97%

EX21:612007123672EX21:612007123672Subsidiarie97%

EX21:61d6efc1490dEX21:61d6efc1490dSubsidiarie97%

EX21:62b444599027EX21:62b444599027Subsidiarie97%

EX21:62c79a7331b0EX21:62c79a7331b0Subsidiarie97%

EX21:62ea9776592bEX21:62ea9776592bSubsidiarie97%

EX21:63da8dba75a4EX21:63da8dba75a4Subsidiarie97%

EX21:63e76a4c0a28EX21:63e76a4c0a28Subsidiarie97%

EX21:644c54fa9e1cEX21:644c54fa9e1cSubsidiarie97%

EX21:64b43d50c13eEX21:64b43d50c13eSubsidiarie97%

EX21:65a7fc74b75aEX21:65a7fc74b75aSubsidiarie97%

EX21:65ca523015c2EX21:65ca523015c2Subsidiarie97%

EX21:65cf62f727fdEX21:65cf62f727fdSubsidiarie97%

EX21:66605c80fe08EX21:66605c80fe08Subsidiarie97%

EX21:66b929d8c475EX21:66b929d8c475Subsidiarie97%

EX21:66e744aa2bc8EX21:66e744aa2bc8Subsidiarie97%

EX21:681735bc3b8eEX21:681735bc3b8eSubsidiarie97%

EX21:688198a1e20cEX21:688198a1e20cSubsidiarie97%

EX21:68bb8dc4b3efEX21:68bb8dc4b3efSubsidiarie97%

EX21:68caffc82860EX21:68caffc82860Subsidiarie97%

EX21:6988331cd24dEX21:6988331cd24dSubsidiarie97%

EX21:6a20421fac1eEX21:6a20421fac1eSubsidiarie97%

EX21:6a63736049e1EX21:6a63736049e1Subsidiarie97%

EX21:6c1047649f10EX21:6c1047649f10Subsidiarie97%

EX21:6c77adcd2226EX21:6c77adcd2226Subsidiarie97%

EX21:6d8991ade45bEX21:6d8991ade45bSubsidiarie97%

EX21:6de83e82683eEX21:6de83e82683eSubsidiarie97%

EX21:6e35e06b1c7cEX21:6e35e06b1c7cSubsidiarie97%

EX21:6e739fc2fc0dEX21:6e739fc2fc0dSubsidiarie97%

EX21:6fc34d389f2fEX21:6fc34d389f2fSubsidiarie97%

EX21:6fd95db50263EX21:6fd95db50263Subsidiarie97%

EX21:703994c46231EX21:703994c46231Subsidiarie97%

EX21:70613e241d83EX21:70613e241d83Subsidiarie97%

EX21:70daba37d0e3EX21:70daba37d0e3Subsidiarie97%

EX21:716196ed593bEX21:716196ed593bSubsidiarie97%

EX21:71e666fe06b4EX21:71e666fe06b4Subsidiarie97%

EX21:738563b15183EX21:738563b15183Subsidiarie97%

EX21:73bacd1a2992EX21:73bacd1a2992Subsidiarie97%

EX21:747a05c8d619EX21:747a05c8d619Subsidiarie97%

EX21:75f972a4c349EX21:75f972a4c349Subsidiarie97%

EX21:762677f81ab0EX21:762677f81ab0Subsidiarie97%

EX21:763fa58140aaEX21:763fa58140aaSubsidiarie97%

EX21:76c071621ca4EX21:76c071621ca4Subsidiarie97%

EX21:7705acd2d158EX21:7705acd2d158Subsidiarie97%

EX21:7793e9837e2bEX21:7793e9837e2bSubsidiarie97%

EX21:77ec102afa5bEX21:77ec102afa5bSubsidiarie97%

EX21:77ed83533a43EX21:77ed83533a43Subsidiarie97%

EX21:77edd50bd550EX21:77edd50bd550Subsidiarie97%

EX21:786896e96fe2EX21:786896e96fe2Subsidiarie97%

EX21:7974676db5faEX21:7974676db5faSubsidiarie97%

EX21:7c140a4be304EX21:7c140a4be304Subsidiarie97%

EX21:7ce1897aa852EX21:7ce1897aa852Subsidiarie97%

EX21:7d15fa263e6aEX21:7d15fa263e6aSubsidiarie97%

EX21:7e8ec5a54492EX21:7e8ec5a54492Subsidiarie97%

EX21:7fa1f69a7ea5EX21:7fa1f69a7ea5Subsidiarie97%

EX21:80f373116aecEX21:80f373116aecSubsidiarie97%

EX21:84eb46f253b6EX21:84eb46f253b6Subsidiarie97%

EX21:856fff721b77EX21:856fff721b77Subsidiarie97%

EX21:85a548fdeb08EX21:85a548fdeb08Subsidiarie97%

EX21:85ed9a1d9a79EX21:85ed9a1d9a79Subsidiarie97%

EX21:8605c36afbfaEX21:8605c36afbfaSubsidiarie97%

EX21:862abfdafaf4EX21:862abfdafaf4Subsidiarie97%

EX21:864dd1762da9EX21:864dd1762da9Subsidiarie97%

EX21:8785ba97cd2eEX21:8785ba97cd2eSubsidiarie97%

EX21:884f4712e284EX21:884f4712e284Subsidiarie97%

EX21:885f570a2a18EX21:885f570a2a18Subsidiarie97%

EX21:88a8292a6670EX21:88a8292a6670Subsidiarie97%

EX21:88d392828c63EX21:88d392828c63Subsidiarie97%

EX21:896e1479336cEX21:896e1479336cSubsidiarie97%

EX21:89d42e9debe0EX21:89d42e9debe0Subsidiarie97%

EX21:8a0471c77464EX21:8a0471c77464Subsidiarie97%

EX21:8a062a46b5bfEX21:8a062a46b5bfSubsidiarie97%

EX21:8a7e2910af01EX21:8a7e2910af01Subsidiarie97%

EX21:8af0be2ad3e0EX21:8af0be2ad3e0Subsidiarie97%

EX21:8b2b1182a786EX21:8b2b1182a786Subsidiarie97%

EX21:8b33f144a51bEX21:8b33f144a51bSubsidiarie97%

EX21:8c47e80a8a97EX21:8c47e80a8a97Subsidiarie97%

EX21:8c6c50657f3aEX21:8c6c50657f3aSubsidiarie97%

EX21:8d87402e40dbEX21:8d87402e40dbSubsidiarie97%

EX21:8ddf811dd60dEX21:8ddf811dd60dSubsidiarie97%

EX21:8ec2fabbb420EX21:8ec2fabbb420Subsidiarie97%

EX21:8f287193b6c3EX21:8f287193b6c3Subsidiarie97%

EX21:90fde27adeafEX21:90fde27adeafSubsidiarie97%

EX21:910aaf85b86dEX21:910aaf85b86dSubsidiarie97%

EX21:911b07a90e3fEX21:911b07a90e3fSubsidiarie97%

EX21:911b1351632dEX21:911b1351632dSubsidiarie97%

EX21:92209a27cb55EX21:92209a27cb55Subsidiarie97%

EX21:92ca9c3c4fa4EX21:92ca9c3c4fa4Subsidiarie97%

EX21:939617976cfeEX21:939617976cfeSubsidiarie97%

EX21:9410cda63bb5EX21:9410cda63bb5Subsidiarie97%

EX21:9466c8ccfdbfEX21:9466c8ccfdbfSubsidiarie97%

EX21:9560aa418bc0EX21:9560aa418bc0Subsidiarie97%

EX21:97bc645e2407EX21:97bc645e2407Subsidiarie97%

EX21:98ff4968e725EX21:98ff4968e725Subsidiarie97%

EX21:9967817bb421EX21:9967817bb421Subsidiarie97%

EX21:999749da0ac2EX21:999749da0ac2Subsidiarie97%

EX21:99c177b00e33EX21:99c177b00e33Subsidiarie97%

EX21:99d84432dedaEX21:99d84432dedaSubsidiarie97%

EX21:99fe8e89e8b3EX21:99fe8e89e8b3Subsidiarie97%

EX21:9a058964066bEX21:9a058964066bSubsidiarie97%

EX21:9a4724cb8e95EX21:9a4724cb8e95Subsidiarie97%

EX21:9a6e1a227ee7EX21:9a6e1a227ee7Subsidiarie97%

EX21:9c660a79b677EX21:9c660a79b677Subsidiarie97%

EX21:9c6f9e9f51a1EX21:9c6f9e9f51a1Subsidiarie97%

EX21:9d04d1e6f7d6EX21:9d04d1e6f7d6Subsidiarie97%

EX21:9d128f250825EX21:9d128f250825Subsidiarie97%

EX21:9d34672a5d78EX21:9d34672a5d78Subsidiarie97%

EX21:9d718ea65520EX21:9d718ea65520Subsidiarie97%

EX21:9ee5d4b212ebEX21:9ee5d4b212ebSubsidiarie97%

EX21:9fdaf36257bbEX21:9fdaf36257bbSubsidiarie97%

EX21:a00bda59b125EX21:a00bda59b125Subsidiarie97%

EX21:a08638390959EX21:a08638390959Subsidiarie97%

EX21:a1497130b820EX21:a1497130b820Subsidiarie97%

EX21:a14b322d9c4cEX21:a14b322d9c4cSubsidiarie97%

EX21:a362f5b6374aEX21:a362f5b6374aSubsidiarie97%

EX21:a43825811081EX21:a43825811081Subsidiarie97%

EX21:a54949ae4b98EX21:a54949ae4b98Subsidiarie97%

EX21:a5d1348a4e1eEX21:a5d1348a4e1eSubsidiarie97%

EX21:a5dd54741c02EX21:a5dd54741c02Subsidiarie97%

EX21:a62d5e043ab1EX21:a62d5e043ab1Subsidiarie97%

EX21:a7246a7b9c6dEX21:a7246a7b9c6dSubsidiarie97%

EX21:a73562cbe08fEX21:a73562cbe08fSubsidiarie97%

EX21:a795da2e0fd9EX21:a795da2e0fd9Subsidiarie97%

EX21:a80c21044e8cEX21:a80c21044e8cSubsidiarie97%

EX21:a88508e5573cEX21:a88508e5573cSubsidiarie97%

EX21:a8fd477c8395EX21:a8fd477c8395Subsidiarie97%

EX21:aa0ae026370dEX21:aa0ae026370dSubsidiarie97%

EX21:aaae9afc8730EX21:aaae9afc8730Subsidiarie97%

EX21:ab53528f3870EX21:ab53528f3870Subsidiarie97%

EX21:ab5ccb3c4017EX21:ab5ccb3c4017Subsidiarie97%

EX21:ad055f088cc6EX21:ad055f088cc6Subsidiarie97%

EX21:ad14f61ddfd0EX21:ad14f61ddfd0Subsidiarie97%

EX21:ad68f87507deEX21:ad68f87507deSubsidiarie97%

EX21:ad8a5d9a3440EX21:ad8a5d9a3440Subsidiarie97%

EX21:ae15f7f34a4cEX21:ae15f7f34a4cSubsidiarie97%

EX21:af344acec53bEX21:af344acec53bSubsidiarie97%

EX21:af948c741ccaEX21:af948c741ccaSubsidiarie97%

EX21:b079e03d8edbEX21:b079e03d8edbSubsidiarie97%

EX21:b1fe88f99649EX21:b1fe88f99649Subsidiarie97%

EX21:b236746045feEX21:b236746045feSubsidiarie97%

EX21:b288fb9e215fEX21:b288fb9e215fSubsidiarie97%

EX21:b544001ee19dEX21:b544001ee19dSubsidiarie97%

EX21:b5760ff4ba4eEX21:b5760ff4ba4eSubsidiarie97%

EX21:b6007cb22865EX21:b6007cb22865Subsidiarie97%

EX21:b61819df457aEX21:b61819df457aSubsidiarie97%

EX21:b71b0c4f8649EX21:b71b0c4f8649Subsidiarie97%

EX21:b73e7000b5a1EX21:b73e7000b5a1Subsidiarie97%

EX21:b76e9d26123eEX21:b76e9d26123eSubsidiarie97%

EX21:b780dd30b551EX21:b780dd30b551Subsidiarie97%

EX21:b7aa87656539EX21:b7aa87656539Subsidiarie97%

EX21:b7baa98635eaEX21:b7baa98635eaSubsidiarie97%

EX21:b802c46b6b00EX21:b802c46b6b00Subsidiarie97%

EX21:b8652e5fc123EX21:b8652e5fc123Subsidiarie97%

EX21:b8bf3e49d467EX21:b8bf3e49d467Subsidiarie97%

EX21:b989fe05e65eEX21:b989fe05e65eSubsidiarie97%

EX21:b9901c0a604cEX21:b9901c0a604cSubsidiarie97%

EX21:ba0c8368a08cEX21:ba0c8368a08cSubsidiarie97%

EX21:ba4e7b46cc4fEX21:ba4e7b46cc4fSubsidiarie97%

EX21:bb49cb89cc32EX21:bb49cb89cc32Subsidiarie97%

EX21:bb57efa7a9f1EX21:bb57efa7a9f1Subsidiarie97%

EX21:bca27fd2cf65EX21:bca27fd2cf65Subsidiarie97%

EX21:bca3685fea8aEX21:bca3685fea8aSubsidiarie97%

EX21:bda67f4cf06aEX21:bda67f4cf06aSubsidiarie97%

EX21:be1d9db2898fEX21:be1d9db2898fSubsidiarie97%

EX21:bf995df65fbeEX21:bf995df65fbeSubsidiarie97%

EX21:bfa72ff1f034EX21:bfa72ff1f034Subsidiarie97%

EX21:bff474f542c9EX21:bff474f542c9Subsidiarie97%

EX21:c054d71bb9c3EX21:c054d71bb9c3Subsidiarie97%

EX21:c0a2d3227dd6EX21:c0a2d3227dd6Subsidiarie97%

EX21:c121469dd72fEX21:c121469dd72fSubsidiarie97%

EX21:c17119a3c4e7EX21:c17119a3c4e7Subsidiarie97%

EX21:c185cf7d7f18EX21:c185cf7d7f18Subsidiarie97%

EX21:c1961b461a2eEX21:c1961b461a2eSubsidiarie97%

EX21:c1d7261f4b8aEX21:c1d7261f4b8aSubsidiarie97%

EX21:c2783c040f16EX21:c2783c040f16Subsidiarie97%

EX21:c2ad9268fc74EX21:c2ad9268fc74Subsidiarie97%

EX21:c38f8cb0d538EX21:c38f8cb0d538Subsidiarie97%

EX21:c6c82abf6926EX21:c6c82abf6926Subsidiarie97%

EX21:c72017ad7baaEX21:c72017ad7baaSubsidiarie97%

EX21:c74de2c0c469EX21:c74de2c0c469Subsidiarie97%

EX21:c7cc4378d7deEX21:c7cc4378d7deSubsidiarie97%

EX21:c7eb7eb48018EX21:c7eb7eb48018Subsidiarie97%

EX21:c8302b1d804cEX21:c8302b1d804cSubsidiarie97%

EX21:c8a9bbb68344EX21:c8a9bbb68344Subsidiarie97%

EX21:c9e31e543251EX21:c9e31e543251Subsidiarie97%

EX21:cab188d1c581EX21:cab188d1c581Subsidiarie97%

EX21:cbeeed4d432fEX21:cbeeed4d432fSubsidiarie97%

EX21:cbf43cf1bdd5EX21:cbf43cf1bdd5Subsidiarie97%

EX21:cc3b17530034EX21:cc3b17530034Subsidiarie97%

EX21:cefc137ca392EX21:cefc137ca392Subsidiarie97%

EX21:cf08cec4ed57EX21:cf08cec4ed57Subsidiarie97%

EX21:d00925d161d7EX21:d00925d161d7Subsidiarie97%

EX21:d02db0c531eeEX21:d02db0c531eeSubsidiarie97%

EX21:d02ebe727dbeEX21:d02ebe727dbeSubsidiarie97%

EX21:d0ce385f9fadEX21:d0ce385f9fadSubsidiarie97%

EX21:d0fa701f6db7EX21:d0fa701f6db7Subsidiarie97%

EX21:d153b5f65757EX21:d153b5f65757Subsidiarie97%

EX21:d1cf30d7384eEX21:d1cf30d7384eSubsidiarie97%

EX21:d2577b845aa1EX21:d2577b845aa1Subsidiarie97%

EX21:d2798dace3bfEX21:d2798dace3bfSubsidiarie97%

EX21:d2daf344ccbcEX21:d2daf344ccbcSubsidiarie97%

EX21:d2f0bc70c5f2EX21:d2f0bc70c5f2Subsidiarie97%

EX21:d39f64a29684EX21:d39f64a29684Subsidiarie97%

EX21:d3b705815dfcEX21:d3b705815dfcSubsidiarie97%

EX21:d45339fb4613EX21:d45339fb4613Subsidiarie97%

EX21:d481bdd8f5a1EX21:d481bdd8f5a1Subsidiarie97%

EX21:d6ee7006cdd2EX21:d6ee7006cdd2Subsidiarie97%

EX21:d7b3122cc8dcEX21:d7b3122cc8dcSubsidiarie97%

EX21:d9f52a13e70dEX21:d9f52a13e70dSubsidiarie97%

EX21:dad9eb3de649EX21:dad9eb3de649Subsidiarie97%

EX21:dc06b8fb7adeEX21:dc06b8fb7adeSubsidiarie97%

EX21:dcbef8ae4c53EX21:dcbef8ae4c53Subsidiarie97%

EX21:dd2acdf0629eEX21:dd2acdf0629eSubsidiarie97%

EX21:dd2dc8df09ceEX21:dd2dc8df09ceSubsidiarie97%

EX21:ddfd81998dc8EX21:ddfd81998dc8Subsidiarie97%

EX21:df18f98a24afEX21:df18f98a24afSubsidiarie97%

EX21:df249f0b898dEX21:df249f0b898dSubsidiarie97%

EX21:dfec596c8aeeEX21:dfec596c8aeeSubsidiarie97%

EX21:e00f31e261b1EX21:e00f31e261b1Subsidiarie97%

EX21:e062f3b6db7eEX21:e062f3b6db7eSubsidiarie97%

EX21:e07f92dfb99aEX21:e07f92dfb99aSubsidiarie97%

EX21:e1d125aa1fa1EX21:e1d125aa1fa1Subsidiarie97%

EX21:e22cc560927bEX21:e22cc560927bSubsidiarie97%

EX21:e231c5ede714EX21:e231c5ede714Subsidiarie97%

EX21:e25be6b23912EX21:e25be6b23912Subsidiarie97%

EX21:e2dfe6038e29EX21:e2dfe6038e29Subsidiarie97%

EX21:e2f9f9aab534EX21:e2f9f9aab534Subsidiarie97%

EX21:e33b3b3ade6aEX21:e33b3b3ade6aSubsidiarie97%

EX21:e4002a8c0346EX21:e4002a8c0346Subsidiarie97%

EX21:e413de30fa6dEX21:e413de30fa6dSubsidiarie97%

EX21:e4cf0a78f1ebEX21:e4cf0a78f1ebSubsidiarie97%

EX21:e52f9640f38aEX21:e52f9640f38aSubsidiarie97%

EX21:e5ab963608b4EX21:e5ab963608b4Subsidiarie97%

EX21:e5ba202915f2EX21:e5ba202915f2Subsidiarie97%

EX21:e5c9493a5a4cEX21:e5c9493a5a4cSubsidiarie97%

EX21:e66b4bb9655dEX21:e66b4bb9655dSubsidiarie97%

EX21:e6a817b37785EX21:e6a817b37785Subsidiarie97%

EX21:e864a2df31b7EX21:e864a2df31b7Subsidiarie97%

EX21:e9a6acb920dbEX21:e9a6acb920dbSubsidiarie97%

EX21:ea3c7a39e0bcEX21:ea3c7a39e0bcSubsidiarie97%

EX21:eaf72fb13d43EX21:eaf72fb13d43Subsidiarie97%

EX21:ed022f96424fEX21:ed022f96424fSubsidiarie97%

EX21:ed6033fe1974EX21:ed6033fe1974Subsidiarie97%

EX21:ede9ba482fdbEX21:ede9ba482fdbSubsidiarie97%

EX21:edeecb2e8efbEX21:edeecb2e8efbSubsidiarie97%

EX21:ee0e708ba080EX21:ee0e708ba080Subsidiarie97%

EX21:f039fbee60bdEX21:f039fbee60bdSubsidiarie97%

EX21:f093c2a03420EX21:f093c2a03420Subsidiarie97%

EX21:f10d07670945EX21:f10d07670945Subsidiarie97%

EX21:f1f913a7da91EX21:f1f913a7da91Subsidiarie97%

EX21:f27eae22a602EX21:f27eae22a602Subsidiarie97%

EX21:f4ce8e73edbbEX21:f4ce8e73edbbSubsidiarie97%

EX21:f6e959ad27b2EX21:f6e959ad27b2Subsidiarie97%

EX21:f76a33a56078EX21:f76a33a56078Subsidiarie97%

EX21:f9c6f29c40f2EX21:f9c6f29c40f2Subsidiarie97%

EX21:fa02de52169cEX21:fa02de52169cSubsidiarie97%

EX21:fa7e9be6c121EX21:fa7e9be6c121Subsidiarie97%

EX21:fafcabfb9d7dEX21:fafcabfb9d7dSubsidiarie97%

EX21:fb273e46b612EX21:fb273e46b612Subsidiarie97%

EX21:fb6e81629cb8EX21:fb6e81629cb8Subsidiarie97%

EX21:fb9a40496b69EX21:fb9a40496b69Subsidiarie97%

EX21:fba25ff85b5bEX21:fba25ff85b5bSubsidiarie97%

EX21:fc150bf9c2d6EX21:fc150bf9c2d6Subsidiarie97%

EX21:fcdb07845833EX21:fcdb07845833Subsidiarie97%

EX21:fcf9d99b2e16EX21:fcf9d99b2e16Subsidiarie97%

EX21:fd2647f24a2eEX21:fd2647f24a2eSubsidiarie97%

EX21:fd447330cc76EX21:fd447330cc76Subsidiarie97%

EX21:fddccb990d01EX21:fddccb990d01Subsidiarie97%

EX21:fee276289843EX21:fee276289843Subsidiarie97%

Supply chain

— missing data

Peer comparison

Peer comparison8 peers · vs REG · multiples and returns

PLD—

Prologis Inc

$144,25

138,1B USD

P/E

40,9x

+13,7 vs self

Div yield

0,0 %

-3,6 vs self

ROE

6,2 %

-1,4 vs self

SPG—

Simon Property Group Inc

$229,16

74,5B USD

P/E

—

— vs self

Div yield

4,2 %

+0,6 vs self

ROE

—

— vs self

O—

Realty Income Corp

$63,58

59,4B USD

P/E

54,5x

+27,2 vs self

Div yield

5,2 %

+1,6 vs self

ROE

2,7 %

-4,9 vs self

BXP—

Bxp Inc

$70,41

11,2B USD

P/E

33,5x

+6,3 vs self

Div yield

—

— vs self

ROE

5,4 %

-2,3 vs self

ARE—

Alexandria Real Estate Equit

$53,03

9,1B USD

P/E

24,1x

-3,1 vs self

Div yield

8,8 %

+5,2 vs self

ROE

2,3 %

-5,3 vs self

KIM—

Kimco Realty Corp

—

P/E

—

— vs self

Div yield

—

— vs self

ROE

—

— vs self

VNO—

Vornado Realty Trust

$39,93

7,6B USD

P/E

8,0x

-19,2 vs self

Div yield

1,9 %

-1,7 vs self

ROE

15,0 %

+7,4 vs self

SWDR—

STARWOOD REAL ESTATE INCOME TRUST, INC.

—

P/E

—

— vs self

Div yield

—

— vs self

ROE

—

— vs self

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

0,18

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-16 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	0,18
Revenue	—no estimate	—no estimate	1,4B AUD
Operating income	—no estimate	—no estimate	82,6M AUD

Full-year consensus mean (period as reported by source) · consensus in AUD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution5 analysts

Strong buy2

Buy2

Hold1

Sell0

Strong sell0

12-month price targetA$8,46 · Median A$8,50

Low A$8,00High A$9,00

Operating income · consensus82,6M AUD

EPS surprise

−12,3 %

reported vs consensus · miss

Revenue surprise

−16,2 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

LowA$8,00

MeanA$8,46

MedianA$8,50

HighA$9,00

SpotA$6,14

+37.8 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin5,2 %Bottom quartile

Net Margin4,2 %Bottom quartile

ROE-292,7 %Bottom quartile

Capex / Rev-7,4 %Below median

D/E-0,31Above P75

Cash Conv6,25Best in class

Corporate actions / M&A

M&A probabilityconf —

Probability

5 %

Base rate

3 %

Band

Moderate

180-day horizon · target 2027-01-16 · 1,8× base rate

No acquirer candidates identified by the signal model.

Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

Derivative transactions

Net acquired 10 347 sh27 exercises · 1 grants11 insiders

BLAIR BRYCEDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
Evens DeirdreDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
Evens DeirdreDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
Klein KarinDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
FURPHY THOMAS WDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
Klein KarinDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
BLANKENSHIP C RONALDDirector · Dividend Equivalent Rights → Common StockDisposed 77exercise · 2026-05-11
BLANKENSHIP C RONALDDirector · Restricted Stock → Common StockDisposed 1 875exercise · 2026-05-11
LINNEMAN PETERDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
LINNEMAN PETERDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
BLAIR BRYCEDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
Simmons James H. IIIDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
FURPHY THOMAS WDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
Simmons James H. IIIDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
Anderson Gary EDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
Campbell Kristin AnnDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
Campbell Kristin AnnDirector · Dividend Equivalent Rights → Common StockDisposed 71exercise · 2026-05-11
Anderson Gary EDirector · Restricted Stock → Common StockDisposed 1 736exercise · 2026-05-11
FURPHY THOMAS WDirector · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06
Evens DeirdreDirector · Restricted Stock Grant → Common StockAcquired 2 340exercise · 2026-05-06
Parrell Mark J.Director · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06
LINNEMAN PETERDirector · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06
Klein KarinDirector · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06
Simmons James H. IIIDirector · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06
Campbell Kristin AnnDirector · Restricted Stock Grant → Common StockAcquired 2 150exercise · 2026-05-06

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

Regis Healthcare Ltd Market data — financials · 2026-05-29
Regis Healthcare Ltd Market data — analyst estimates · 2026-05-29

Ownership & reference

Insider activity

Net selling0 buys · 7 sellsnet -$35,3M13 insiders · last 365d

Devereaux Terah LPrincipal Accounting Officer · Common StockSold 1 240 @ $80,14$99K · 2026-06-12
Devereaux Terah LPrincipal Accounting Officer · Common StockOther 620 · 2026-06-12
Simmons James H. IIIDirector · Common StockOther 1 736 · 2026-05-11
BLAIR BRYCEDirector · Common StockOther 1 736 · 2026-05-11
BLAIR BRYCEDirector · Common StockOther 71 · 2026-05-11
LINNEMAN PETERDirector · Common StockOther 1 736 · 2026-05-11
LINNEMAN PETERDirector · Common StockOther 71 · 2026-05-11
BLANKENSHIP C RONALDDirector · Common StockOther 1 875 · 2026-05-11
BLANKENSHIP C RONALDDirector · Common StockOther 77 · 2026-05-11
Klein KarinDirector · Common StockOther 1 736 · 2026-05-11
Klein KarinDirector · Common StockOther 71 · 2026-05-11
Evens DeirdreDirector · Common StockOther 1 736 · 2026-05-11
Evens DeirdreDirector · Common StockOther 71 · 2026-05-11
FURPHY THOMAS WDirector · Common StockOther 1 736 · 2026-05-11
FURPHY THOMAS WDirector · Common StockOther 71 · 2026-05-11
Campbell Kristin AnnDirector · Common StockOther 1 736 · 2026-05-11
Campbell Kristin AnnDirector · Common StockOther 71 · 2026-05-11
Anderson Gary EDirector · Common StockOther 1 736 · 2026-05-11
Anderson Gary EDirector · Common StockOther 71 · 2026-05-11
Simmons James H. IIIDirector · Common StockOther 71 · 2026-05-11
BLANKENSHIP C RONALDDirector · Common StockOther 453 · 2026-05-06
Parrell Mark J.Director · Common StockOther 352 · 2026-05-06
LINNEMAN PETERDirector · Common StockOther 336 · 2026-05-06
Klein KarinDirector · Common StockOther 403 · 2026-05-06
WIBBENMEYER NICHOLAS ANDREWW. Regional Pres. & CIO · Common StockSold 7 927 @ $79,06$627K · 2026-05-05

Short positioning

6.1Mshares short+3.2% vs prior

5.19days to cover

49.4%short of daily vol

145fails-to-deliver

as of 2026-07-15 · short-interest report (free)

Index membership

S&P/ASX 200

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

REG.AXCanonical

ASX · AUD

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Relationship graph

This companySectorSubsidiaries

Evidence & claims

From filings & derived data

Net margin (FY 2025-12-31): 34.0%Derived (calculated)
Return on assets (FY 2025-12-31): 4.1%Derived (calculated)
Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 4.7%Derived (calculated)
Return on equity (FY 2025-12-31): 7.6%Derived (calculated)
Debt-to-equity (FY 2025-12-31): 0.84xDerived (calculated)
Operating income (YoY) (2025-12-31 vs 2024-12-31): 7.3%Derived (calculated)
Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 6.0%Derived (calculated)
Total assets (YoY) (2025-12-31 vs 2024-12-31): 4.9%Derived (calculated)
Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 2.7%Derived (calculated)
Revenue (YoY) (2025-12-31 vs 2024-12-31): 6.9%Derived (calculated)
Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 7.5%Derived (calculated)
Net income (YoY) (2025-12-31 vs 2024-12-31): 31.7%Derived (calculated)
Total operating expenses (annual): USD 970.46MSEC XBRL filing
Operating income (annual): USD 1.12BSEC XBRL filing
Shares outstanding (annual): 182.9MSEC XBRL filing
Total liabilities (annual): USD 5.82BSEC XBRL filing
Total assets (annual): USD 13BSEC XBRL filing
Shareholders' equity (annual): USD 6.91BSEC XBRL filing
Revenue (annual): USD 1.55BSEC XBRL filing
Operating cash flow (annual): USD 827.69MSEC XBRL filing
Net income (annual): USD 527.46MSEC XBRL filing
Long-term debt (annual): USD 4.74BSEC XBRL filing
Operating cash flow (YoY) (2024-12-31 vs 2023-12-31): 9.8%Derived (calculated)
Net income (YoY) (2024-12-31 vs 2023-12-31): 9.8%Derived (calculated)

Showing 24 of 60 surfaced claims.

Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

The Thread

Everything we know, in order

2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date

2026-07-30 04:36 UTCFILINGMaterial 8-K

2026-07-30EVENTQ2 2026 earnings (confirmed · filed)

2026-07-29 00:00 UTCTRANSCRIPTEarnings call — Q3 2026

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)

2026-06-21 02:57 UTCHOLDERInstitutional holding changed

2026-06-21 02:57 UTCHOLDER29 institutional position changes flagged

2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated

2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated

2026-06-12 00:00 UTCINSIDER2 insider transactions — 2026-06

2026-06-12INSIDERDevereaux Terah L sold 1.2k sh — Principal Accounting Officer ~$99k

2026-06-12INSIDERDevereaux Terah L transacted 620 sh — Principal Accounting Officer

2026-06-01FILING8-K filing →

2026-05-28FILING8-K filing →

2026-05-27FILING8-K filing →

2026-05-18FILING8-K filing →

2026-05-11 00:00 UTCINSIDER53 insider transactions — 2026-05 · net sell $22.2M 27 derivative

2026-05-11INSIDERSimmons James H. III transacted 1.7k sh — Director

2026-05-11INSIDERBLAIR BRYCE transacted 1.7k sh — Director

2026-05-11INSIDERBLAIR BRYCE transacted 71 sh — Director

2026-05-11INSIDERLINNEMAN PETER transacted 1.7k sh — Director

2026-05-11INSIDERLINNEMAN PETER transacted 71 sh — Director

2026-05-11INSIDERBLANKENSHIP C RONALD transacted 1.9k sh — Director

Showing the 40 most recent of 85 entries.

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Derivative transactions

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread